Track every registration update on the InsiderAlpha IPO tracker.
Updated Jul 16, 2026 · Last SEC filing 2026-06-17
Hemab Therapeutics Holdings, Inc. (COAG) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-17. 3 Form 8-K material event filings were reported by COAG in the last 90 days. InsiderAlpha tracks every COAG SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0002114044 |
|---|
| Form 4 filings (90d) | 9 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Latest Form 4 filing | 2026-06-17 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 61.5K | $24.98 | $1.54M | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 6.1K | $24.89 | $153K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 996 | $24.94 | $25K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 3.8K | $24.97 | $95K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 6.4K | $24.90 | $159K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 25.7K | $25.00 | $643K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 14.1K | $24.47 | $346K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 1.5K | $24.98 | $37K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 7.9K | $24.34 | $193K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 2.0K | $24.95 | $50K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 53.4K | $24.83 | $1.33M | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 14.6K | $23.77 | $347K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 87.1K | $24.59 | $2.14M | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 10.3K | $25.00 | $257K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 2.54M | $18.00 | $45.74M | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Hemab Therapeutics Holdings, Inc. (COAG). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 25 | $55.46M |
| MARAGANORE JOHN | 5 | — |
| Novo Holdings A/S | 5 | — |
| Madigan Catherine | 2 | — |
| Behrndt-Eriksen Mads Nikolaj | 2 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in COAG insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live COAG dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.